Detalles de la búsqueda
1.
In situ tumour arrays reveal early environmental control of cancer immunity.
Nature
; 618(7966): 827-833, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37258670
2.
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer.
Cancer Immunol Immunother
; 73(4): 72, 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430405
3.
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
Breast Cancer Res Treat
; 204(1): 123-132, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019444
4.
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
Oncologist
; 28(7): 640-e559, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129455
5.
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
N Engl J Med
; 383(14): 1328-1339, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997907
6.
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 41(3): 493-502, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171722
7.
JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.
Cancer
; 128(1): 65-74, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478166
8.
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer.
Cancer
; 128(9): 1801-1811, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195913
9.
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings.
Oncologist
; 27(3): 175-182, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274716
10.
A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.
BMC Cancer
; 22(1): 502, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524219
11.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144482
12.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339623
13.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280658
14.
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Future Oncol
; 17(10): 1165-1184, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583206
15.
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Proc Natl Acad Sci U S A
; 115(43): E10119-E10126, 2018 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30297397
16.
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 20(4): 518-530, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30857956
17.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420467
18.
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 24(6): e251-e259, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30139835
19.
Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply.
N Engl J Med
; 384(6): 584-585, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567202
20.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262187